Response by Good et al to Letter Regarding Article, "Pannexin-1 Channels as an Unexpected New Target of the Antihypertensive Drug Spironolactone"
- PMID: 29798905
- PMCID: PMC6051405
- DOI: 10.1161/CIRCRESAHA.118.313080
Response by Good et al to Letter Regarding Article, "Pannexin-1 Channels as an Unexpected New Target of the Antihypertensive Drug Spironolactone"
Comment on
-
Pannexin 1 Channels as an Unexpected New Target of the Anti-Hypertensive Drug Spironolactone.Circ Res. 2018 Feb 16;122(4):606-615. doi: 10.1161/CIRCRESAHA.117.312380. Epub 2017 Dec 13. Circ Res. 2018. PMID: 29237722 Free PMC article.
-
Letter by Angus and Wright Regarding Article, "Pannexin-1 Channels as an Unexpected New Target of the Antihypertensive Drug Spironolactone".Circ Res. 2018 May 25;122(11):e86-e87. doi: 10.1161/CIRCRESAHA.118.313062. Circ Res. 2018. PMID: 29798904 No abstract available.
References
-
- Angus JA, Betrie AH, Wright CE. Pannexin-1 channels do not regulate alpha1-adrenoceptor-mediated vasoconstriction in resistance arteries. Eur J Pharmacol. 2015;750:43–51. - PubMed
-
- Angus JA, Wright CE. ATP is not involved in alpha1-adrenoceptor-mediated vasoconstriction in resistance arteries. Eur J Pharmacol. 2015;769:162–6. - PubMed
-
- D’Hondt C, Ponsaerts R, De Smedt H, Bultynck G, Himpens B. Pannexins, distant relatives of the connexin family with specific cellular functions? Bioessays. 2009;31:953–74. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical